查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786884

临床肿瘤学次世代定序市场，规模，占有率，趋势，产业分析报告:各技术，工作流程，各用途，各最终用途，各地区，2025年～2034年的市场预测

Clinical Oncology Next Generation Sequencing Market Size, Share, Trends, Industry Analysis Report By Technology (Whole Genome Sequencing, Whole Exome Sequencing), By Workflow, By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，临床肿瘤学新一代定序 (NGS) 市场规模预计到2034年将达到22.0879亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

临床肿瘤学新一代定序 (NGS) 是一种高通量基因组技术，能够全面分析肿瘤DNA和RNA，从而识别致癌突变、拷贝数变异、基因融合和其他分子变异。这项技术正在彻底改变精准肿瘤学，使临床医生能够以前所未有的精确度识别可操作的分子标靶、预测治疗反应并监测病情进展。

新一代定序透过识别新型生物标记物并招募患者参与基因型匹配的临床试验，推动了癌症研究的发展。儘管该技术具有变革性的潜力，但也面临着肿瘤异质性、复杂的数据解读和成本障碍等课题。然而，单细胞定序、长读长技术和人工智慧的进步正在提高新一代定序的准确性和可及性，从而推动市场成长。

临床肿瘤学新一代定序市场报告重点

就技术而言，标靶定序和重定序领域预计将在2024年占据64.93%的市场收入占有率，这得益于成本效益、深度覆盖以及能够聚焦特定基因或基因组区域的优势。

按工作流程划分，预计定序领域在2024年将占据57.03%的市场收入占有率，这得益于对能够准确分析癌症基因组的高通量、高精度和高性价比平台的需求激增。

依应用划分，伴随诊断领域在2024年以71.83%的营收占有率领先市场。这种主导地位归因于FDA批准的相关基因生物标记的抗癌药物数量的增加。

依最终用途划分，由于向分散检测和即时诊断的转变，临床领域预计在未来几年的复合年增长率将达到19.21%。

在2024年全球临床肿瘤学次世代定序 (NGS) 市场中，北美占44.16%的市占率。这种主导地位归因于癌症的高发生率、先进的医疗基础设施以及精准医疗的广泛应用。

由于癌症患者数量的增加、政府的支持性政策以及对基因组医学的投资不断增加，预计到 2034 年，欧洲市场将占据相当大的市场占有率。

预计亚太地区市场在预测期内将达到最高的复合年增长率。这是由于癌症负担的增加、医疗保健可近性的改善以及对基因组医学的投资增加。

全球主要市场参与者包括安捷伦科技、Eurofins Scientific S.E.、F. Hoffmann-La Roche Ltd.、Illumina, Inc.、Myriad Genetics、Oxford Nanopore Technologies Ltd.、Pacific Bioscience、Perkin Elmer、Qiagen N.V. 和赛默飞世尔科技。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球临床肿瘤学次世代定序市场洞察

  • 市场概述
  • 临床肿瘤学次世代定序市场动态
    • 促进因素和机会
      • 科技进步加速，
      • 医疗成本不断上涨
    • 限制与课题
      • 成本高昂
  • PESTEL分析
  • 临床肿瘤学次世代定序市场趋势
  • 价值链分析

第5章 全球临床肿瘤学次世代定序市场:各技术

  • 主要调查结果
  • 简介
  • 全基因排列分析
  • 全外显子定序
  • 标靶定序与重定序

第6章 全球临床肿瘤学次世代定序市场:各用途

  • 主要调查结果
  • 简介
  • 筛检
  • 伴随式诊断
  • 其他

第7章 全球临床肿瘤学次世代定序市场:工作流程

  • 主要调查结果
  • 简介
  • 前序列
  • 定序
  • 资料分析

第8章 全球临床肿瘤学次世代定序市场:各最终用途

  • 主要调查结果
  • 简介
  • 医院
  • 诊所
  • 其他

第9章 全球临床肿瘤学次世代定序市场:各地区

  • 主要调查结果
  • 简介
    • 临床肿瘤学次世代定序市场评估:各地区，2020～2034年
  • 北美
    • 北美:各技术，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各工作流程，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各技术，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各工作流程，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各技术，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:各工作流程，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各技术，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各工作流程，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各技术，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各工作流程，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Agilent Technologies
  • Eurofins Scientific S.E.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Myriad Genetics
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience
  • Perkin Elmer
  • Qiagen N.V.
  • Thermo Fisher Scientific
Product Code: PM5960

The Clinical oncology next generation sequencing (NGS) market size is expected to reach USD 2,208.79 million by 2034, according to a new study by Polaris Market Research. The report "Clinical Oncology Next Generation Sequencing Market Share, Size, Trends, Industry Analysis Report By Technology (Whole Genome Sequencing, Whole Exome Sequencing), By Workflow, By Application, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical oncology next generation sequencing (NGS) is a high-throughput genomic technology that enables comprehensive analysis of tumor DNA and RNA to identify cancer-driving mutations, copy number variations, gene fusions, and other molecular alterations. This technology is revolutionizing precision oncology by allowing clinicians to identify actionable molecular targets, predict treatment responses, and monitor disease progression with unprecedented accuracy.

Next generation sequencing fuels cancer research by identifying novel biomarkers and enrolling patients in genotype-matched clinical trials. Despite its transformative potential, the technology faces challenges such as tumor heterogeneity, data interpretation complexity, and cost barriers. However, advancements in single-cell sequencing, long-read technologies, and artificial intelligence are enhancing NGS accuracy and accessibility, driving market growth.

Clinical Oncology Next Generation Sequencing Market Report Highlights

In terms of technology, the targeted sequencing & resequencing segment accounted for 64.93% of market revenue share in 2024 due to its cost-effectiveness, high depth of coverage, and ability to focus on specific genes or genomic regions.

Based on workflow, the sequencing segment held 57.03% of market revenue share in 2024 due to a surge in demand for high-throughput, accurate, and cost-efficient platforms capable of analyzing cancer genomes with increased precision.

In terms of application, the companion diagnostics segment led the market in 2024 by capturing 71.83% revenue share. This dominance is attributed to the rising number of FDA-approved cancer drugs with associated genetic biomarkers.

Based on end use, the clinics segment is projected to register a CAGR of 19.21% in the coming years, owing to the shift toward decentralized testing and point-of-care diagnostics.

North America accounted for a 44.16% share of the global clinical oncology next generation sequencing (NGS) market in 2024. This dominance is attributed to the high prevalence of cancer, advanced healthcare infrastructure, and strong adoption of precision medicine.

The market in Europe is projected to hold a substantial market share in 2034, owing to increasing cancer cases, supportive government policies, and rising investments in genomic medicine.

The market in Asia Pacific is expected to register the highest CAGR during the forecast period, owing to the rising cancer burden, improving healthcare access, and increasing investments in genomics.

A few global key market players include Agilent Technologies; Eurofins Scientific S.E.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Myriad Genetics; Oxford Nanopore Technologies Ltd.; Pacific Bioscience; Perkin Elmer; Qiagen N.V.; and Thermo Fisher Scientific.

Polaris Market Research has segmented the clinical oncology next generation sequencing market report on the basis of technology, workflow, application, end use, and region:

By Technology Outlook (Revenue, USD Million, 2020-2034)

Whole Genome Sequencing

Whole Exome Sequencing

Targeted Sequencing & Resequencing

By Workflow Outlook (Revenue, USD Million, 2020-2034)

Pre-Sequencing

Sequencing

Data Analysis

By Application Outlook (Revenue, USD Million, 2020-2034)

Screening

Sporadic Cancer

Inherited Cancer

Companion Diagnostics

Other

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Clinics

Laboratories

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Clinical Oncology Next Generation Sequencing Market Insights

  • 4.1. Clinical Oncology Next Generation Sequencing Market - Market Snapshot
  • 4.2. Clinical Oncology Next Generation Sequencing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Technological Advancements,
      • 4.2.1.2. Rising Healthcare Spending
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Clinical Oncology Next Generation Sequencing Market Trends
  • 4.6. Value Chain Analysis

5. Global Clinical Oncology Next Generation Sequencing Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • 5.3. Whole Genome Sequencing
    • 5.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Whole Genome Sequencing, by Region, 2020-2034 (USD Million)
  • 5.4. Whole Exome Sequencing
    • 5.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Whole Exome Sequencing, by Region, 2020-2034 (USD Million)
  • 5.5. Targeted Sequencing & Resequencing
    • 5.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Targeted Sequencing & Resequencing, by Region, 2020-2034 (USD Million)

6. Global Clinical Oncology Next Generation Sequencing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • 6.3. Screening
    • 6.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Screening, by Region, 2020-2034 (USD Million)
    • 6.3.2. Sporadic Cancer
      • 6.3.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Sporadic Cancer, by Region, 2020-2034 (USD Million)
    • 6.3.3. Inherited Cancer
      • 6.3.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Inherited Cancer, by Region, 2020-2034 (USD Million)
  • 6.4. Companion Diagnostics
    • 6.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Companion Diagnostics, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Clinical Oncology Next Generation Sequencing Market, by Workflow

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • 7.3. Pre-Sequencing
    • 7.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Pre-Sequencing, by Region, 2020-2034 (USD Million)
  • 7.4. Sequencing
    • 7.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Sequencing, by Region, 2020-2034 (USD Million)
  • 7.5. Data Analysis
    • 7.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Data Analysis, by Region, 2020-2034 (USD Million)

8. Global Clinical Oncology Next Generation Sequencing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 8.3. Hospitals
    • 8.3.1. Global Clinical Oncology Next Generation Sequencing Market, by Hospitals, by Region, 2020-2034 (USD Million)
  • 8.4. Clinics
    • 8.4.1. Global Clinical Oncology Next Generation Sequencing Market, by Clinics, by Region, 2020-2034 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Clinical Oncology Next Generation Sequencing Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Clinical Oncology Next Generation Sequencing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Clinical Oncology Next Generation Sequencing Market Assessment, By Geography, 2020-2034 (USD Million)
  • 9.3. Clinical Oncology Next Generation Sequencing Market - North America
    • 9.3.1. North America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.2. North America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.3.3. North America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.3.4. North America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.3.5. Clinical Oncology Next Generation Sequencing Market - US
      • 9.3.5.1. US: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.3.5.2. US: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.3.5.3. US: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.3.5.4. US: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.3.6. Clinical Oncology Next Generation Sequencing Market - Canada
      • 9.3.6.1. Canada: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.3.6.2. Canada: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.3.6.3. Canada: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.3.6.4. Canada: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.4. Clinical Oncology Next Generation Sequencing Market - Europe
    • 9.4.1. Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.2. Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.4.3. Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.4.4. Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.5. Clinical Oncology Next Generation Sequencing Market - UK
      • 9.4.5.1. UK: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.5.2. UK: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.5.3. UK: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.5.4. UK: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.6. Clinical Oncology Next Generation Sequencing Market - France
      • 9.4.6.1. France: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.6.2. France: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.6.3. France: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.6.4. France: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.7. Clinical Oncology Next Generation Sequencing Market - Germany
      • 9.4.7.1. Germany: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.7.2. Germany: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.7.3. Germany: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.7.4. Germany: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.8. Clinical Oncology Next Generation Sequencing Market - Italy
      • 9.4.8.1. Italy: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.8.2. Italy: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.8.3. Italy: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.8.4. Italy: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.9. Clinical Oncology Next Generation Sequencing Market - Spain
      • 9.4.9.1. Spain: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.9.2. Spain: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.9.3. Spain: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.9.4. Spain: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.10. Clinical Oncology Next Generation Sequencing Market - Netherlands
      • 9.4.10.1. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.10.2. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.10.3. Netherlands: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.10.4. Netherlands: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.11. Clinical Oncology Next Generation Sequencing Market - Russia
      • 9.4.11.1. Russia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.11.2. Russia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.11.3. Russia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.11.4. Russia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.4.12. Clinical Oncology Next Generation Sequencing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.4.12.2. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.4.12.3. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.4.12.4. Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.5. Clinical Oncology Next Generation Sequencing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.2. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.5.3. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.5.4. Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.5. Clinical Oncology Next Generation Sequencing Market - China
      • 9.5.5.1. China: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.5.2. China: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.5.3. China: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.5.4. China: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.6. Clinical Oncology Next Generation Sequencing Market - India
      • 9.5.6.1. India: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.6.2. India: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.6.3. India: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.6.4. India: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.7. Clinical Oncology Next Generation Sequencing Market - Malaysia
      • 9.5.7.1. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.7.2. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.7.3. Malaysia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.7.4. Malaysia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.8. Clinical Oncology Next Generation Sequencing Market - Japan
      • 9.5.8.1. Japan: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.8.2. Japan: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.8.3. Japan: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.8.4. Japan: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.9. Clinical Oncology Next Generation Sequencing Market - Indonesia
      • 9.5.9.1. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.9.2. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.9.3. Indonesia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.9.4. Indonesia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.10. Clinical Oncology Next Generation Sequencing Market - South Korea
      • 9.5.10.1. South Korea: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.10.2. South Korea: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.10.3. South Korea: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.10.4. South Korea: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.11. Clinical Oncology Next Generation Sequencing Market - Australia
      • 9.5.11.1. Australia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.11.2. Australia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.11.3. Australia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.11.4. Australia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.5.12. Clinical Oncology Next Generation Sequencing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.6. Clinical Oncology Next Generation Sequencing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.2. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.6.3. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.6.4. Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.5. Clinical Oncology Next Generation Sequencing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.5.2. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.5.3. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.5.4. Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.6. Clinical Oncology Next Generation Sequencing Market - UAE
      • 9.6.6.1. UAE: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.6.2. UAE: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.6.3. UAE: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.6.4. UAE: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.7. Clinical Oncology Next Generation Sequencing Market - Israel
      • 9.6.7.1. Israel: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.7.2. Israel: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.7.3. Israel: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.7.4. Israel: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.8. Clinical Oncology Next Generation Sequencing Market - South Africa
      • 9.6.8.1. South Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.8.2. South Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.8.3. South Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.8.4. South Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.6.9. Clinical Oncology Next Generation Sequencing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • 9.7. Clinical Oncology Next Generation Sequencing Market - Latin America
    • 9.7.1. Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.2. Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
    • 9.7.3. Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
    • 9.7.4. Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.5. Clinical Oncology Next Generation Sequencing Market - Mexico
      • 9.7.5.1. Mexico: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.5.2. Mexico: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.5.3. Mexico: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.5.4. Mexico: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.6. Clinical Oncology Next Generation Sequencing Market - Brazil
      • 9.7.6.1. Brazil: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.6.2. Brazil: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.6.3. Brazil: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.6.4. Brazil: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.7. Clinical Oncology Next Generation Sequencing Market - Argentina
      • 9.7.7.1. Argentina: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.7.2. Argentina: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.7.3. Argentina: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.7.4. Argentina: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
    • 9.7.8. Clinical Oncology Next Generation Sequencing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
      • 9.7.8.2. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
      • 9.7.8.3. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
      • 9.7.8.4. Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Eurofins Scientific S.E.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. F. Hoffmann-La Roche Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Illumina, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Myriad Genetics
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Oxford Nanopore Technologies Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Pacific Bioscience
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Perkin Elmer
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Qiagen N.V.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables:

  • Table 1 Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 2 Global Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 4 Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 5 North America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 6 North America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 7 North America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 8 North America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 9 U.S.: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 10 U.S.: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 11 U.S.: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 12 U.S.: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Canada: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 14 Canada: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 15 Canada: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 16 Canada: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 18 Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 19 Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 20 Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 21 UK: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 22 UK: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 23 UK: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 24 UK: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 25 France: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 26 France: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 27 France: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 28 France: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 29 Germany: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 30 Germany: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 31 Germany: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 32 Germany: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Italy: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 34 Italy: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 35 Italy: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 36 Italy: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Spain: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 38 Spain: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 39 Spain: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 40 Spain: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 42 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 43 Netherlands: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 44 Netherlands: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Russia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 46 Russia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 47 Russia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 48 Russia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 50 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 51 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 52 Rest of Europe: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 53 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 54 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 55 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 56 Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 57 China: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 58 China: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 59 China: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 60 China: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 61 India: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 62 India: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 63 India: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 64 India: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 66 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 67 Malaysia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 68 Malaysia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 69 Japan: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 70 Japan: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 71 Japan: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 72 Japan: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 73 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 74 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 75 Indonesia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 76 Indonesia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 77 South Korea: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 78 South Korea: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 79 South Korea: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 80 South Korea: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 81 Australia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 82 Australia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 83 Australia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 84 Australia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 86 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 87 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 88 Rest of Asia Pacific: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 89 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 90 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 91 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 92 Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 93 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 94 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 95 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 96 Saudi Arabia: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 97 UAE: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 98 UAE: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 99 UAE: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 100 UAE: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 101 Israel: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 102 Israel: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 103 Israel: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 104 Israel: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 105 South Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 106 South Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 107 South Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 108 South Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 109 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 110 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 111 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 112 Rest of Middle East & Africa: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 113 Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 114 Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 115 Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 116 Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 117 Mexico: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 118 Mexico: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 119 Mexico: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 120 Mexico: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 121 Brazil: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 122 Brazil: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 123 Brazil: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 124 Brazil: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 125 Argentina: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 126 Argentina: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 127 Argentina: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 128 Argentina: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)
  • Table 129 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2034 (USD Million)
  • Table 130 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2034 (USD Million)
  • Table 131 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2034 (USD Million)
  • Table 132 Rest of Latin America: Clinical Oncology Next Generation Sequencing Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Clinical Oncology Next Generation Sequencing Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Clinical Oncology Next Generation Sequencing Market, by Technology, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Clinical Oncology Next Generation Sequencing Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by Workflow
  • Figure 11. Global Clinical Oncology Next Generation Sequencing Market, by Workflow, 2024 & 2034 (USD Million)
  • Figure 12. Market by End Use
  • Figure 13. Global Clinical Oncology Next Generation Sequencing Market, by End Use, 2024 & 2034 (USD Million)